Placebo-controlled double-blind dose-response study of the non-purine-selective xanthine oxidase inhibitor febuxostat (TMX-67) in patients with hyperuricemia (including gout patients) in japan: late phase 2 clinical study (Q84305970)
Jump to navigation
Jump to search
scientific article published on 01 June 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Placebo-controlled double-blind dose-response study of the non-purine-selective xanthine oxidase inhibitor febuxostat (TMX-67) in patients with hyperuricemia (including gout patients) in japan: late phase 2 clinical study |
scientific article published on 01 June 2011 |
Statements
Placebo-controlled double-blind dose-response study of the non-purine-selective xanthine oxidase inhibitor febuxostat (TMX-67) in patients with hyperuricemia (including gout patients) in japan: late phase 2 clinical study (English)
Naoyuki Kamatani
Shin Fujimori
Toshikazu Hada
Tatsuo Hosoya
Kenjiro Kohri
Toshitaka Nakamura
Takanori Ueda
Tetsuya Yamamoto
Yuji Matsuzawa